For research use only. Not for therapeutic Use.
Esmolol(Cat No.:I027016)is a selective beta-1 adrenergic blocker primarily used to manage acute conditions like supraventricular tachycardia (SVT), atrial fibrillation, and other arrhythmias. It works by blocking the effects of adrenaline on the heart, slowing the heart rate and reducing myocardial oxygen demand. Esmolol is known for its rapid onset and short half-life, making it ideal for acute use in critical care settings, such as during surgery or in emergency situations. Side effects may include hypotension, bradycardia, or fatigue. It is typically administered intravenously under close medical supervision.
Catalog Number | I027016 |
CAS Number | 81147-92-4 |
Synonyms | Esmolol; (+-)-Esmolol; ASL 8052-001 |
Molecular Formula | C16H25NO4 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate |
InChI | InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3 |
InChIKey | AQNDDEOPVVGCPG-UHFFFAOYSA-N |
SMILES | CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O |